What You Should Know:
- AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera.
- AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and
Read More
Mercom: Global Digital Health VC Funding Down 6% at $8.9B in 2019
- New Mercom Capital annual report reveals global venture capital (VC) funding in digital health declined 6% at $8.9B compared to $9.5B in 2018. - Total corporate funding into Digital Health – including VC funding, debt, and public market funding - dropped 18% to $10.6 billion in 2019 compared to $13 billion in 2018.- Five digital health IPOs brought in a total of $1.4 billion in 2019Global venture capital (VC) funding in digital health, including private equity and corporate venture, declined
Read More
Top 60 Health IT/Digital Health Mergers & Acquisitions in 2019
- From Google's acquisition of Fitbit to Philips acquisition of Carestream Health's health IT business, here is a look at some of the biggest health IT/digital health mergers & acquisitions in 2019 by each quarter.
Q1 M&A Activity
Johnson & Johnson Acquires Auris Health for $3.4B to Expand Digital Surgery Portfolio
Johnson & Johnson acquiresAuris Health, a developer of robotic technologies for $3.4 billion in cash. Auris Health is a privately-held developer of
Read More
Global Digital Health VC Funding Breaks $5.1B in First Half of 2019
Global venture capital (VC) funding in digital health/health IT, including private equity and corporate venture capital, reach $5.1 billion in the first half of 2019, according to market research firm Mercom Capital. The 1H and Q2 2019 Digital Health (Healthcare IT) Funding and M&A Report reveals $5.1B in funding across 318 deals compared to $4.9B across 383 deals in 1H 2018. Q2 2019 VC funding held strong at $3.1 billion in 169 deals following the $2 billion raised in 149 deals in Q1 2019.
Read More
Dassault Systèmes Acquires Clinical Trial Platform Medidata for $5.8B
French technology giant Dassault Systèmes has agreed to acquire Medidata, a life sciences digital transformation company in an all-cash deal for $92.25 per share valued at $5.8 billion. With the acquisition of Medidata and its clinical and commercial solutions, Dassault Systèmes plans to increase market penetration into the Life Sciences industry with an integrated business experience platform for an end-to-end approach to research and discovery, development, clinical testing, manufacturing and
Read More
Medidata Launches New Life Sciences Company, Acorn AI
Life sciences digital transformation company Medidata, today announced the launch of Acorn AI, a new company designed to provide actionable insights across the entire drug continuum – from R&D to commercialization. In addition, the company has appointed Rama Kondru, Ph.D., as the chief information officer for Medidata and Acorn AI’s first CIO to lead the company’s enterprise data strategy, architecture and future platform development – all helping the company to accelerate the creation of
Read More
Novartis, SHYFT Partner to Support the Commercialization of Key Therapies in Europe
SHYFT Analytics, a Medidata Solutions, today announced that Novartis has selected its Intelligent Platform for Life Sciences to support the commercialization of key therapies in Europe. As part of the collaboration, Novartis will use the following SHYFT solutions: - STRATA Data Platform to aggregate and manage a growing number of third party and proprietary commercial data sources- LUMEN Insights Platform to deliver intuitively-designed analytics to drive the “next-best-actions” for commercial
Read More
Medidata Acquires SHYFT Analytics for $195M to Power Digital Transformation in Life Sciences
Medidata today announced that it has entered into a definitive agreement to acquire SHYFT Analytics for $195 million in cash, closing the loop on clinical development with commercial and real-world data analytics. SHYFT Analytics cloud data analytics platform for life sciences provides insights on 45B patient records and 2M providers. Medidata's unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech,
Read More
Medidata, Syapse Partner to Democratize Access to Oncology Clinical Trials
Medidata, a provider of cloud-based technology and data analytics for clinical research, and Syapse, a precision medicine solutions provider, have announced a new partnership to transform oncology clinical trials for the age of precision medicine. As part of the new partnership, Medidata and Syapse will jointly develop a portfolio of solutions to make it easier for cancer patients to access potentially life-saving clinical trials,Partnership DetailsThe partnership will initially build products
Read More
Medidata to Acquire Mytrus to Transform Clinical Trial Patient Experience
Medidata, a provider of cloud-based solutions and data analytics for clinical research has agreed to acquire Mytrus, Incorporated, an e-clinical technology company specializing in patient-centered electronic informed consent (eConsent) and virtual trials. Financial terms of the acquisition were not disclosed.Medidata will integrate Enroll™, Mytrus’ eConsent solution, into the Medidata Clinical Cloud as part of its ongoing commitment to modernize clinical trials for patients, sites and sponsors.
Read More
